Importance of long-term anticoagulation in both prosthetic and biological tricuspid valve replacements.
Rafiq
Isma
I
Freeman
Leisa J
LJ
Wood
Sheila
S
D000015:Abnormalities, Multiple / Q000601:surgery; D000925:Anticoagulants / Q000008:administration & dosage*; D001705:Bioprosthesis; D006348:Cardiac Surgical Procedures / Q000009:adverse effects / Q000379:methods; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006330:Heart Defects, Congenital / Q000175:diagnosis / Q000601:surgery; D006345:Heart Septal Defects, Ventricular / Q000175:diagnosis / Q000601:surgery; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D007223:Infant; D011182:Postoperative Care; D013923:Thromboembolism / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome; D014262:Tricuspid Valve Insufficiency / Q000209:etiology / Q000601:surgery*; D014859:Warfarin / Q000008:administration & dosage*
D000925:Anticoagulants; D014859:Warfarin